Clinical Trial Update: Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of rosuvastatin in combination with ezetimibe for primary hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Primary Hypercholesterolemia | Phase 3 | Status: COMPLETED